IFP Advisors Inc Grows Position in Eastman Chemical Company $EMN

Key Points

• IFP Advisors Inc significantly increased its stake in Eastman Chemical Company by 875.5% during the second quarter, bringing their total holdings to 11,696 shares valued at approximately $873,000.
• Analysts have mixed views on Eastman Chemical, with Wells Fargo raising its price target from $70.00 to $80.00 while Goldman Sachs lowered its target from $87.00 to $65.00, resulting in an average consensus price target of $85.54.
• Eastman Chemical recently announced a quarterly dividend of $0.83 per share, translating to an annualized dividend yield of 5.5% after a payout ratio of 46.63%.

IFP Advisors Inc grew its stake in shares of Eastman Chemical Company (NYSE:EMN - Free Report) by 875.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,696 shares of the basic materials company's stock after purchasing an additional 10,497 shares during the quarter. IFP Advisors Inc's holdings in Eastman Chemical were worth $873,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Eastman Chemical by 65.5% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 369 shares of the basic materials company's stock valued at $28,000 after purchasing an additional 146 shares during the period. Ameritas Advisory Services LLC purchased a new stake in shares of Eastman Chemical during the second quarter valued at approximately $32,000. National Pension Service boosted its stake in shares of Eastman Chemical by 75.3% during the first quarter. National Pension Service now owns 433 shares of the basic materials company's stock valued at $38,000 after purchasing an additional 186 shares during the period. TD Private Client Wealth LLC boosted its stake in shares of Eastman Chemical by 46.4% during the first quarter. TD Private Client Wealth LLC now owns 536 shares of the basic materials company's stock valued at $47,000 after purchasing an additional 170 shares during the period. Finally, Wayfinding Financial LLC purchased a new stake in shares of Eastman Chemical during the first quarter valued at approximately $50,000. Hedge funds and other institutional investors own 83.65% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Wells Fargo & Company raised their price target on Eastman Chemical from $70.00 to $80.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 16th. The Goldman Sachs Group dropped their price target on Eastman Chemical from $87.00 to $65.00 and set a "neutral" rating for the company in a research note on Thursday, August 7th. Mizuho dropped their price target on Eastman Chemical from $80.00 to $75.00 and set an "outperform" rating for the company in a research note on Friday, October 3rd. KeyCorp set a $79.00 price target on Eastman Chemical and gave the stock an "overweight" rating in a research note on Monday, August 4th. Finally, Citigroup raised their price target on Eastman Chemical from $68.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 2nd. Eight research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $85.54.

Eastman Chemical Stock Up 3.2%

Shares of EMN stock opened at $60.09 on Tuesday. The stock's 50-day simple moving average is $65.14 and its 200-day simple moving average is $73.58. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.78 and a current ratio of 1.68. The firm has a market capitalization of $6.90 billion, a PE ratio of 8.44, a P/E/G ratio of 5.79 and a beta of 1.29. Eastman Chemical Company has a fifty-two week low of $56.78 and a fifty-two week high of $111.79.

Eastman Chemical (NYSE:EMN - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The basic materials company reported $1.60 earnings per share for the quarter, missing analysts' consensus estimates of $1.72 by ($0.12). The firm had revenue of $2.29 billion during the quarter, compared to analyst estimates of $2.32 billion. Eastman Chemical had a net margin of 8.96% and a return on equity of 15.24%. The firm's revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $2.15 earnings per share. Eastman Chemical has set its Q3 2025 guidance at 1.250-1.250 EPS. Equities analysts expect that Eastman Chemical Company will post 8.55 earnings per share for the current year.

Eastman Chemical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, October 7th. Investors of record on Monday, September 15th were issued a dividend of $0.83 per share. This represents a $3.32 annualized dividend and a yield of 5.5%. The ex-dividend date of this dividend was Monday, September 15th. Eastman Chemical's dividend payout ratio (DPR) is 46.63%.

About Eastman Chemical

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical Company (NYSE:EMN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.